Proximity to expertise, access to highly educated talent, availability of move-in ready lab space, and room to grow touted as key factors for choosing Fitzsimons for its Colorado headquarters
AURORA, Colo. (November 13, 2024) – Fitzsimons Innovation Community, an integrated campus of leading-edge facilities for innovative health and life sciences companies, announces RefinedScience, a Colorado high-tech biosciences company working to transform precision drug development, has selected the Community for its Colorado headquarters. To accelerate its path to market, RefinedScience will transition from The Foundry, a CU Innovations incubator housed in Bioscience 1, to permanent lab and office space in Bioscience 3 at Fitzsimons Innovation Community.
RefinedScience is an emerging Colorado company changing the way data is used to improve patient outcomes. From deep data analysis, the company designs smarter clinical trials that can move previously stalled drugs through the clinical stage and on to market where they can start helping patients. Started as part of CU Innovations, RefinedScience has evolved from a clinical decision support tool into a novel new precision medicine platform.
The leadership team looked at other cities for life sciences incubation and development, and ultimately chose Fitzsimons Innovation Community to allow them to remain close to the team of experts they consult on the University of Colorado Anschutz Medical Campus and to have custom lab space in the right size for their initial location, knowing that the room they need to grow is available to them when they’re ready. With new hires on the horizon, a location in Colorado also gives them access to the highly educated talent pool for which the state is known.
Executive Quotes
Erik Johnson, CEO of RefinedScience, said, “We were born out of this University (of Colorado), and we continue to have extremely strong ties to it. We’ve obviously evolved and now have our own identity, too, but we’ve learned that bringing the best of academia and the best of industry together can create the best company, so we never want to lose that connection.”
Kimberly Muller, Executive Director of CU Innovations, co-founder of RefinedScience, said, “The success of RefinedScience strengthens CU Innovations’ leadership in precision medicine. This endeavor is reshaping the very landscape of clinical trial design. Fitzsimons Innovation Community has the infrastructure in place to support our bold approach which promises to accelerate discoveries, propelling us towards tailored therapies that cater to the unique needs of each patient.
Steve VanNurden, President and CEO of Fitzsimons Innovation Community, said, “Companies see the thriving ecosystem we’ve built and want to be part of it. With our proximity to University of Colorado Anschutz Medical Campus, our competitive advantage is the cooperation we’ve established between the hospitals including UCHealth and Children’s Hospital Colorado, our Community, and the academic medical campus. So, when a company comes on campus, they get connected into all of these resources, giving them a higher chance of being successful here.”
David Saad, Executive Vice President of CBRE, the leasing partner for Fitzsimons Innovation Community said, “Fitzsimons Innovation Community is as a one-of-a-kind development offering world-class amenities to attract and retain life sciences companies for their full life cycle. All of the components for an thriving ecosystem exist on the campus from incubation space to graduate lab space and manufacturing capabilities to great restaurants, hotels, and access to public transit—all within walking distance.”
Learn more about RefinedScience at www.refinedscience.com.
ABOUT FITZSIMONS INNOVATION COMMUNITY
At Fitzsimons Innovation Community, visionaries boldly transform science into the future of health and care. Fitzsimons Innovation Community pushes boundaries in a unified pursuit of health breakthroughs. From concept through commercialization, organizations choose Fitzsimons Innovation Community for its entrepreneurial environment, leading-edge facilities, and campus-wide support. Visionaries discover, develop, and collaborate with direct access to the renowned clinicians and researchers at the University of Colorado Anschutz Medical Campus. We are united to advance health. To learn more, please visit our website: www.fitzsimonsinnovation.com.
Media Resources
Interviews and images available upon request.
Media Contacts
Fitzsimons Innovation Community
Annie Coghill, 303-547-6692
annie@theprimaveragroup.com
